HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 276, Issue 32, 29729-29739, August 10, 2001

This Article Full Text Full Text (PDF) All Versions of this Article: 276/32/29729    most recent M101167200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, B. Articles by Lee, M. Y. W. Search for Related Content PubMed PubMed Citation Articles by Li, B. Articles by Lee, M. Y. W. Social Bookmarking                      What's this?

Transcriptional Regulation of the Human DNA Polymerase  Catalytic Subunit Gene POLD1 by p53 Tumor Suppressor and Sp1^*

Baoqing Li and Marietta Y. W. Lee

From the Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, New York 10595

The DNA polymerase  catalytic subunit gene (POLD1) was studied as a transcriptional target of p53. Northern blotting showed that a significantly decreased steady-state level of POLD1 mRNA was associated with increased wild-type p53 expression in cells treated with methyl methanesulfonate. When ectopic wild-type p53 expression was induced to a physiologically relevant level in "tet-off" cultured cells in which p53 expression was tightly regulated by tetracycline, it was found that POLD1 steady-state mRNA was repressed by about 65%. Transient cotransfection experiments using a POLD1 promoter luciferase reporter construct showed that: (i) POLD1 promoter activity was inhibited by transfected wild-type p53 plasmid to a maximum of about 86%; (ii) p53 mediated a large part of the transcriptional repression through a sequence-specific interaction with a site identified as the P4 site of the POLD1 promoter; (iii) tumor-derived p53 mutations in the p53 DNA-binding domain completely abolished the p53 transrepression activity. Moreover, transfection assays demonstrated that p53 was able to repress Sp1-stimulated POLD1 promoter activity and that this repression was largely due to the loss of the sequence-specific interaction between Sp1 protein and the P4 Sp1-binding site, which overlaps the P4 p53-binding site. Finally, gel shift assays suggested that p53 competes with Sp1 protein for binding to the P4 sequence of the POLD1 promoter.

work was supported by National Institutes of Health Grant GM 31973.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				K. Kumamoto, E. A. Spillare, K. Fujita, I. Horikawa, T. Yamashita, E. Appella, M. Nagashima, S. Takenoshita, J. Yokota, and C. C. Harris Nutlin-3a Activates p53 to Both Down-regulate Inhibitor of Growth 2 and Up-regulate mir-34a, mir-34b, and mir-34c Expression, and Induce Senescence Cancer Res., May 1, 2008; 68(9): 3193 - 3203. [Abstract] [Full Text] [PDF]

				A. Zaky, C. Busso, T. Izumi, R. Chattopadhyay, A. Bassiouny, S. Mitra, and K. K. Bhakat Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage Nucleic Acids Res., March 1, 2008; 36(5): 1555 - 1566. [Abstract] [Full Text] [PDF]

				M. Hosokawa, A. Takehara, K. Matsuda, H. Eguchi, H. Ohigashi, O. Ishikawa, Y. Shinomura, K. Imai, Y. Nakamura, and H. Nakagawa Oncogenic Role of KIAA0101 Interacting with Proliferating Cell Nuclear Antigen in Pancreatic Cancer Cancer Res., March 15, 2007; 67(6): 2568 - 2576. [Abstract] [Full Text] [PDF]

				D. Van Bodegom, Z. Saifudeen, S. Dipp, S. Puri, B. S. Magenheimer, J. P. Calvet, and S. S. El-Dahr The Polycystic Kidney Disease-1 Gene Is a Target for p53-mediated Transcriptional Repression J. Biol. Chem., October 20, 2006; 281(42): 31234 - 31244. [Abstract] [Full Text] [PDF]

				I. Shats, M. Milyavsky, X. Tang, P. Stambolsky, N. Erez, R. Brosh, I. Kogan, I. Braunstein, M. Tzukerman, D. Ginsberg, et al. p53-dependent Down-regulation of Telomerase Is Mediated by p21waf1 J. Biol. Chem., December 3, 2004; 279(49): 50976 - 50985. [Abstract] [Full Text] [PDF]

				K. Lohr, C. Moritz, A. Contente, and M. Dobbelstein p21/CDKN1A Mediates Negative Regulation of Transcription by p53 J. Biol. Chem., August 29, 2003; 278(35): 32507 - 32516. [Abstract] [Full Text] [PDF]

				T. Watanabe, M. Sugaya, A. M. Atkins, E. A. Aquilino, A. Yang, D. L. Borris, J. Brady, and A. Blauvelt Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial Cells J. Virol., June 1, 2003; 77(11): 6188 - 6196. [Abstract] [Full Text] [PDF]

				H.-J. Im, M. R. Pittelkow, and R. Kumar Divergent Regulation of the Growth-promoting Gene IEX-1 by the p53 Tumor Suppressor and Sp1 J. Biol. Chem., April 19, 2002; 277(17): 14612 - 14621. [Abstract] [Full Text] [PDF]